Evidence map›Paper›PMID 36572998›Full record

ArticleEpigenetics2023

Non-pathogenic microbiota accelerate age-related CpG Island methylation in colonic mucosa.

Ang Sun, Pyounghwa Park, Lauren Cole, Himani Vaidya, Shinji Maegawa, Kelsey Keith, Gennaro Calendo, Jozef Madzo, Jaroslav Jelinek, Christian Jobin and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Epigenetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Epigenetic differences in the tumor suppressor genesInnovative surgical sciences · 2024
    Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Ang SunFels Cancer Institute for Personalized Medicine, Temple University School of Medicine, Philadelphia, PA, United States.ORCID 0000-0002-8644-0407
Pyounghwa ParkFels Cancer Institute for Personalized Medicine, Temple University School of Medicine, Philadelphia, PA, United States.ORCID 0000-0002-5850-6181
Lauren ColeFels Cancer Institute for Personalized Medicine, Temple University School of Medicine, Philadelphia, PA, United States.
Himani VaidyaFels Cancer Institute for Personalized Medicine, Temple University School of Medicine, Philadelphia, PA, United States.ORCID 0000-0002-2779-3069
Shinji MaegawaFels Cancer Institute for Personalized Medicine, Temple University School of Medicine, Philadelphia, PA, United States.ORCID 0000-0003-2057-7854
Kelsey KeithFels Cancer Institute for Personalized Medicine, Temple University School of Medicine, Philadelphia, PA, United States.ORCID 0000-0002-7451-5117
Gennaro CalendoCoriell Institute for Medical Research, Camden, NJ, United States.ORCID 0000-0002-4510-5530
Jozef MadzoFels Cancer Institute for Personalized Medicine, Temple University School of Medicine, Philadelphia, PA, United States.ORCID 0000-0001-6607-1213
Jaroslav JelinekFels Cancer Institute for Personalized Medicine, Temple University School of Medicine, Philadelphia, PA, United States.ORCID 0000-0002-2533-0220
Christian JobinDepartment of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, University of Florida College of Medicine, Gainesville, Florida, USA.ORCID 0000-0002-3733-1001
Jean-Pierre J IssaFels Cancer Institute for Personalized Medicine, Temple University School of Medicine, Philadelphia, PA, United States.ORCID 0000-0003-2258-5030
Coriell Institute For Medical Research · USTemple University · USThe University of Texas MD Anderson Cancer Center · USUniversity of Florida · US

Funding

Pathology CoreP50CA254897 · NCI · CORIELL INSTITUTE FOR MEDICAL RESEARCH · PI ISSA, JEAN-PIERRE J. · 2021 to 2025
$11.9M
Role of the microbiota in DNA methylation and CRC developmentR01CA214005 · NCI · TEMPLE UNIV OF THE COMMONWEALTH · PI ISSA, JEAN-PIERRE J., JOBIN, CHRISTIAN · 2018 to 2022
$2.9M
NCI NIH HHS P50 CA254897NCI NIH HHS R01 CA214005
6 · The paper itself

Abstract

DNA methylation is an epigenetic process altered in cancer and ageing. Age-related methylation drift can be used to estimate lifespan and can be influenced by extrinsic factors such as diet. Here, we report that non-pathogenic microbiota accelerate age-related methylation drift in the colon when compared with germ-free mice. DNA methylation analyses showed that microbiota and IL10KO were associated with changes in 5% and 4.1% of CpG sites, while mice with both factors had 18% alterations. Microbiota, IL10KO, and their combination altered 0.4%, 0.4%, and 4% of CpG island methylation, respectively. These are comparable to what is seen in colon cancer. Ageing changes were accelerated in the IL10KO mice with microbiota, and the affected genes were more likely to be altered in colon cancer. Thus, the microbiota affect DNA methylation of the colon in patterns reminiscent of what is observed in ageing and colorectal cancer.

Indexed as

Colonic NeoplasmsColorectal NeoplasmsMicrobiotaAnimalsCpG IslandsDNA MethylationMiceMucous MembraneAgeingDNA methylationGerm-freeInflammationMicrobiota

Identifiers

PMID36572998
PMCPMC9980687
OpenAlexW4313236396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.